These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19423568)
1. Phosphate levels and cardiovascular disease in the general population. Foley RN Clin J Am Soc Nephrol; 2009 Jun; 4(6):1136-9. PubMed ID: 19423568 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. West SL; Swan VJ; Jamal SA Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502 [TBL] [Abstract][Full Text] [Related]
3. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification. Saab G; Whaley-Connell AT; Khanna R; Sowers JR Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399 [TBL] [Abstract][Full Text] [Related]
4. Phosphate: a stealthier killer than previously thought? Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627 [TBL] [Abstract][Full Text] [Related]
5. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk. Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672 [TBL] [Abstract][Full Text] [Related]
11. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Ferro CJ; Chue CD; Steeds RP; Townend JN Heart; 2009 Nov; 95(21):1770-2. PubMed ID: 19321494 [TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Vervloet MG; van Ballegooijen AJ Kidney Int; 2018 May; 93(5):1060-1072. PubMed ID: 29580635 [TBL] [Abstract][Full Text] [Related]
13. Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern. Shimada M; Shutto-Uchita Y; Yamabe H In Vivo; 2019; 33(1):11-16. PubMed ID: 30587596 [TBL] [Abstract][Full Text] [Related]
14. Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study. Foley RN; Collins AJ; Herzog CA; Ishani A; Kalra PA Kidney Blood Press Res; 2009; 32(1):37-44. PubMed ID: 19229116 [TBL] [Abstract][Full Text] [Related]
15. Dietary phosphorus, serum phosphorus, and cardiovascular disease. Menon MC; Ix JH Ann N Y Acad Sci; 2013 Oct; 1301():21-6. PubMed ID: 24117725 [TBL] [Abstract][Full Text] [Related]
16. [Hyperphosphatemia and cardiovascular diseases : impact of vascular calcification and endothelial dysfunction]. Iijima K Clin Calcium; 2012 Oct; 22(10):1505-13. PubMed ID: 23023630 [TBL] [Abstract][Full Text] [Related]
17. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review. Sigrist MK; Chiarelli G; Lim L; Levin A J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735 [TBL] [Abstract][Full Text] [Related]
19. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia. Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775 [TBL] [Abstract][Full Text] [Related]
20. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence? Orth SR; Hallan SI Clin J Am Soc Nephrol; 2008 Jan; 3(1):226-36. PubMed ID: 18003763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]